Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 42291-635

11 FDA label images from Avkare · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 42291-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Oxybutynin 1)

Chemical Structure (Oxybutynin 1)
Chemical structure diagram of oxybutynin chloride, showing its molecular components and arrangement including the hydrochloride group.*
FDA Label Image

Figure 1 (Oxybutynin 2)

Figure 1 (Oxybutynin 2)
A line chart comparing the mean plasma oxybutynin concentration (ng/mL) over 24 hours between oxybutynin chloride extended-release tablets and oxybutynin 5 mg taken three times daily (TID). The x-axis represents time in hours, and the y-axis shows plasma concentration, with error bars indicating variability at each time point.*
FDA Label Image

Figure 2 (Oxybutynin 3)

Figure 2 (Oxybutynin 3)
A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) over time (hours), with data points at 0, 4, 6, 8, and 24 hours. The graph depicts a slight initial increase in concentration followed by a gradual decrease, including error bars around each data point.*
FDA Label Image

Figure 2 (Oxybutynin 4)

Figure 2 (Oxybutynin 4)
A horizontal bar chart comparing the mean change in episodes per week from baseline for Oxybutynin chloride extended-release tablets versus placebo. The chart displays mean changes with standard deviation error bars on a scale from -40 to 40 episodes.*
FDA Label Image

Figure 3 (Oxybutynin 5)

Figure 3 (Oxybutynin 5)
A horizontal bar chart displaying mean changes with standard deviation in episodes per week from baseline for oxybutynin chloride extended-release tablets. The x-axis measures change in episodes per week ranging from -40 to 40, with a data point indicated near -20 for oxybutynin.*
FDA Label Image

Figure 4 (Oxybutynin 6)

Figure 4 (Oxybutynin 6)
A line graph depicting the mean change with standard deviation in episodes per week from baseline for oxybutynin chloride extended-release tablets compared to oxybutynin, with the horizontal axis showing values from -40 to 40.*
FDA Label Image

1 (633 01)

1 (633 01)
Label for Oxybutynin Chloride Extended-Release Tablets USP 5 mg by AvKARE. The label shows 100 tablets for oral use, marked Rx only. It includes storage instructions and a barcode with NDC 42291-633-01.*
FDA Label Image

2 (633 50)

2 (633 50)
Oxybutynin Chloride Extended-Release Tablets USP 5 mg, oral tablets in a 500-count bottle labeled by AvKARE. The label includes dosage strength, quantity, and controlled substance information, along with storage instructions and a barcode.*
FDA Label Image

100 (634 01)

100 (634 01)
Oxybutynin Chloride Extended Release 10 mg tablets, USP, in a package containing 100 tablets. The label shows the brand AvKARE, NDC 42291-634-01, indicating this is an oral extended-release tablet formulation. The label includes storage instructions, manufacturer details, and a barcode.*
FDA Label Image

500 (634 50)

500 (634 50)
Label for Oxybutynin Chloride Extended-Release Tablets USP 10 mg by AvKARE. The label indicates the product contains 500 tablets, is for oral use, and is prescription-only. Dosage instructions and storage conditions are also printed, including a barcode, QR code, and NDC 42291-634-50.*
FDA Label Image

100 (635 01)

100 (635 01)
Label for Oxybutynin Chloride Extended-Release Tablets USP, 15 mg strength, oral tablets. The label indicates 100 tablets in the package, prescription only. It includes manufacturer AvKARE information and storage instructions, with a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.